Cannabis Report
Home > Boards > US Listed > Biotechs >

Eagle Pharmaceuticals, inc. (EGRX)

EGRX RSS Feed
Add EGRX Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 4/3/2018 11:06:02 AM - Followers: 18 - Board type: Free - Posts Today: 0
Cannabis Report
EGRX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
EGRX News: Eagle Pharmaceuticals, Inc. to Present at Morgan Stanley 16th Annual Global Healthcare Conference 09/04/2018 04:30:00 PM
EGRX News: Current Report Filing (8-k) 08/30/2018 07:05:19 AM
EGRX News: Eagle Pharmaceuticals Concludes Enrollment of Second Safety & Efficacy Study at Hajj to Evaluate RYANODEX for Exertional Heat... 08/30/2018 07:00:00 AM
EGRX News: Eagle Pharmaceuticals Named to Fortune 100 List of Fastest-Growing Companies 08/23/2018 07:00:00 AM
EGRX News: Eagle Pharmaceuticals Announces New Patent Issued for BENDEKA 08/22/2018 09:02:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#585   What is going on with this stock? Just Denairo 04/03/18 11:06:02 AM
#584   Scott Tariff on Biologics acquisition Bickema 02/26/18 02:05:24 PM
#583   http://investor.eagleus.com/press-release/eagle-pharmaceuticals-inc-reports-four Bickema 02/26/18 10:10:28 AM
#582   WIth a market cap of 880 million and Bickema 02/13/18 10:20:06 AM
#581   Have not been here in quite a while, Denairo 02/12/18 06:29:52 PM
#580   Dew how much of the 700 EV for Bickema 12/11/17 12:31:33 PM
#579   big news Only 40 mil market cap cash make it happen 11/17/17 11:05:25 AM
#578   Eagle Pharmaceuticals Announces Positive Results of Study Conducted Bickema 09/05/17 02:52:28 PM
#577   Suing the FDA for Bendeka's Orphan application was GD 07/27/17 11:26:53 AM
#576   Classic Scott Tarriff.... A typical salesman without situational stugwins 07/27/17 10:56:24 AM
#575   EGRX receives CRL for Ryanodex in heatstroke: #msg-133316969. DewDiligence 07/26/17 12:37:18 PM
#574   Too hot to handle: Study shows Earth's killer Bickema 06/19/17 01:45:46 PM
#573   Class action lawsuit update bio_fan 05/23/17 12:39:50 PM
#572   Replacing a CFO is one of the biggest W4 05/17/17 09:54:07 AM
#571   What about at the beginning CEO said more GD 05/11/17 01:52:30 PM
#570   Interesting comment from the Deutsche Bank conference about bio_fan 05/11/17 12:50:06 PM
#569   EGRX is acting strange(strong), is buyout from TEVA GD 05/10/17 01:38:34 PM
#568   FDA Grants Priority Review for Eagle Pharmaceuticals’ Ryanodex Bickema 03/27/17 09:01:57 AM
#567   EGRX Financial Update as of 12/31/16 from JP Bickema 01/12/17 07:38:01 PM
#566   Eli Lilly's Alimta escapes early generics—and a sales Bickema 01/12/17 07:07:18 PM
#565   This was the first 2017 guidance for Bendeka/Treanda, DewDiligence 01/09/17 09:47:24 AM
#564   But why did TEVA lower their sales guidance? jsmith77 01/09/17 09:23:26 AM
#563   Low 2017 sales guidance for Bendeks/Treanda. DewDiligence 01/09/17 09:21:02 AM
#562   What was the reasoning for the drop? jsmith77 01/09/17 09:19:59 AM
#561   EGRX -7% on TEVA’s 2017 guidance: #msg-127680719. DewDiligence 01/06/17 01:56:00 PM
#560   [OT]—MNTA's first NVS partnership deal (for generic Lovenox) DewDiligence 12/19/16 04:39:51 PM
#559   Dew are you aware that MNTA's former CEO Bickema 12/19/16 04:15:37 PM
#558   Something to note here is that Eagle's largest Bickema 12/18/16 11:50:45 AM
#557   Instead of me trying to articulate why this stugwins 11/17/16 03:49:08 PM
#556   msg was duplicated. Wouldn't let me delete this one. bio_fan 11/17/16 08:33:15 AM
#555   "Who knows what Biogen and the other companies bio_fan 11/17/16 08:30:38 AM
#554   Ryanodex is looking like its going to bring jsmith77 11/15/16 10:08:41 AM
#553   That's the problem with intellectual lightweights (Tarriff is stugwins 11/13/16 02:57:49 PM
#552   I guess Biogen and 11 other companies that bio_fan 11/12/16 09:40:38 PM
#551   Agreed (eom). DewDiligence 11/11/16 11:15:27 AM
#550   Dew, I fully understand your disappointment. stugwins 11/11/16 11:13:40 AM
#549   I cashed out today (#msg-126485051), so I'm resigning DewDiligence 11/11/16 10:22:49 AM
#548   I wasn't expecting this move (see bottom of DewDiligence 11/11/16 10:00:49 AM
#547   Eagle Pharmaceuticals Initiates Rolling Submission of NDA for Bickema 11/11/16 09:41:55 AM
#546   Eagle Pharmaceuticals Signs Definitive Agreement to Acquire Arsia Bickema 11/11/16 09:40:24 AM
#545   Very nice! DewDiligence 11/09/16 04:48:37 PM
#544   In regards to milestone, the answer is yes Bickema 11/09/16 04:31:57 PM
#543   Eagle Pharmaceuticals, Inc. Reports Third Quarter 2016 Results Bickema 11/09/16 08:36:55 AM
#542   The Bendeka "take-back" rights apply only when there DewDiligence 11/03/16 01:49:51 PM
#541   Mizuho increases PT to 78. bio_fan 11/03/16 01:35:39 PM
#540   Very unclear, however the market reaction is impressive Bickema 11/02/16 10:16:13 AM
#539   Unclear, but I would think the PR would DewDiligence 11/02/16 09:56:17 AM
#538   There's apparently no milestone payment for the (delayed) DewDiligence 11/02/16 09:52:13 AM
#537   Looking back at the agreement with teva. bio_fan 11/02/16 09:47:22 AM
#536   Unique J-code for Bendeka bio_fan 11/02/16 09:02:04 AM
PostSubject